These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 30986950)

  • 1. Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses.
    Becker T; Le-Trilling VTK; Trilling M
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
    Flores-Martínez YA; Le-Trilling VTK; Trilling M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx.
    Landsberg CD; Megger DA; Hotter D; Rückborn MU; Eilbrecht M; Rashidi-Alavijeh J; Howe S; Heinrichs S; Sauter D; Sitek B; Le-Trilling VTK; Trilling M
    Front Immunol; 2018; 9():2978. PubMed ID: 30619335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into Viral Hijacking of CRL4 Ubiquitin Ligase through Structural Analysis of the pUL145-DDB1 Complex.
    Wick ET; Treadway CJ; Li Z; Nicely NI; Ren Z; Baldwin AS; Xiong Y; Harrison JS; Brown NG
    J Virol; 2022 Sep; 96(17):e0082622. PubMed ID: 35938868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
    Lutz LM; Pace CR; Arnold MM
    J Virol; 2016 Jul; 90(13):6036-48. PubMed ID: 27099313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Human Cytomegalovirus pUL145 Isoforms Act as Viral DDB1-Cullin-Associated Factors to Instruct Host Protein Degradation to Impede Innate Immunity.
    Le-Trilling VTK; Becker T; Nachshon A; Stern-Ginossar N; Schöler L; Voigt S; Hengel H; Trilling M
    Cell Rep; 2020 Feb; 30(7):2248-2260.e5. PubMed ID: 32075763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ub to no good: How cytomegaloviruses exploit the ubiquitin proteasome system.
    Le-Trilling VTK; Trilling M
    Virus Res; 2020 May; 281():197938. PubMed ID: 32198076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin-RING Ligases as attractive anti-cancer targets.
    Zhao Y; Sun Y
    Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.
    Nguyen HC; Wang W; Xiong Y
    Subcell Biochem; 2017; 83():323-347. PubMed ID: 28271482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul I; Uttenweiler-Joseph S; Moog-Lutz C; Lutz PG
    Biochimie; 2016 Mar; 122():339-47. PubMed ID: 26253693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation.
    Lu G; Yi J; Gubas A; Wang YT; Wu Y; Ren Y; Wu M; Shi Y; Ouyang C; Tan HWS; Wang T; Wang L; Yang ND; Deng S; Xia D; Chen RH; Tooze SA; Shen HM
    Autophagy; 2019 Nov; 15(11):1917-1934. PubMed ID: 30898011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad and potent antiviral activity of the NAE inhibitor MLN4924.
    Le-Trilling VT; Megger DA; Katschinski B; Landsberg CD; Rückborn MU; Tao S; Krawczyk A; Bayer W; Drexler I; Tenbusch M; Sitek B; Trilling M
    Sci Rep; 2016 Feb; 6():19977. PubMed ID: 26829401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
    Villeneuve NF; Lau A; Zhang DD
    Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.
    Arend KC; Lenarcic EM; Vincent HA; Rashid N; Lazear E; McDonald IM; Gilbert TS; East MP; Herring LE; Johnson GL; Graves LM; Moorman NJ
    Mol Cell Proteomics; 2017 Apr; 16(4 suppl 1):S263-S276. PubMed ID: 28237943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug targets in cytomegalovirus infection.
    Andrei G; De Clercq E; Snoeck R
    Infect Disord Drug Targets; 2009 Apr; 9(2):201-22. PubMed ID: 19275707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.
    Ramirez PW; DePaula-Silva AB; Szaniawski M; Barker E; Bosque A; Planelles V
    Retrovirology; 2015 Jul; 12():65. PubMed ID: 26215564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of Cullin-RING Ubiquitin Ligases in Cardiovascular Diseases.
    Diaz S; Wang K; Sjögren B; Liu X
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer.
    Soucy TA; Smith PG; Rolfe M
    Clin Cancer Res; 2009 Jun; 15(12):3912-6. PubMed ID: 19509147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.
    Wildum S; Zimmermann H; Lischka P
    Antimicrob Agents Chemother; 2015; 59(6):3140-8. PubMed ID: 25779572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.
    Kim W; Lee S; Son Y; Ko C; Ryu WS
    J Virol; 2016 Nov; 90(21):9644-9653. PubMed ID: 27535046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.